Timothy J. Marsh

Timothy J. Marsh has extensive experience in the field of biomedical research. Timothy J. has worked at multiple prestigious institutions, including Casma Therapeutics, the University of California, San Francisco, and Harvard Medical School.

At Casma Therapeutics, Timothy held the position of Senior Scientist I, where they have been working since February 2022. Timothy J. previously served as a Scientist II from April 2021 to January 2022, and as a Scientist I from March 2020 to March 2021.

Prior to their time at Casma Therapeutics, Timothy worked at the University of California, San Francisco as a Postdoctoral Research Fellow from September 2019 to January 2020. As a PhD Student at the same institution from September 2013 to August 2019, they conducted research on compound transgenic mouse models to study tumor cell autophagy and its impact on metastatic progression. Timothy J. also gained experience in project management and academic collaborations, resulting in 12 publications.

Before joining the University of California, San Francisco, Timothy held the position of Lab Manager/Research Technician II at Harvard Medical School from September 2010 to August 2013. In this role, they focused on studying systemic signaling between tumors and the recruitment of bone marrow derived cell subpopulations in tumor microenvironments. Timothy J.'sresearch contributed to the publication of 5 scientific papers.

Overall, Timothy J. Marsh's work experience demonstrates their expertise in biomedical research, particularly in the areas of cancer biology, tumor microenvironments, and autophagy.

Timothy J. Marsh pursued their education in a diligent and focused manner, acquiring notable qualifications. From 2006 to 2010, they attended Skidmore College, where they obtained two Bachelor of Arts degrees. Timothy J.'sfields of study during this time were neuroscience and psychology, although specific information about their focus within these fields is not provided. Subsequently, Timothy furthered their academic pursuit by enrolling at the University of California, San Francisco, where they completed their doctoral studies in biomedical sciences. This extensive endeavor spanned from 2013 to 2019, demonstrating their commitment to research and their dedication to advancing knowledge in the medical field.